A
Abecma
Abecma (idecabtagene vicleucel) is a genetically modified autologous T cell immunotherapy directed against B-cell maturation antigen (BCMA), approved for intra…
Targeted Cancer Therapies medicines and related generic ingredients.
Abecma (idecabtagene vicleucel) is a genetically modified autologous T cell immunotherapy directed against B-cell maturation antigen (BCMA), approved for intra…
Alecensa is an oral medication containing alectinib, approved for treating adults with ALK-positive non-small cell lung cancer (NSCLC). It is used both after t…
Alunbrig is an oral kinase inhibitor approved for treating adult patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer …
Blincyto (blinatumomab) is an intravenous injection used to treat certain types of CD19-positive B-cell precursor acute lymphoblastic leukemia (ALL). It is app…